» Articles » PMID: 12486173

Mice Lacking D5 Dopamine Receptors Have Increased Sympathetic Tone and Are Hypertensive

Abstract

Dopamine is an important transmitter in the CNS and PNS, critically regulating numerous neuropsychiatric and physiological functions. These actions of dopamine are mediated by five distinct receptor subtypes. Of these receptors, probably the least understood in terms of physiological functions is the D5 receptor subtype. To better understand the role of the D5 dopamine receptor (DAR) in normal physiology and behavior, we have now used gene-targeting technology to create mice that lack this receptor subtype. We find that the D5 receptor-deficient mice are viable and fertile and appear to develop normally. No compensatory alterations in other dopamine receptor subtypes were observed. We find, however, that the mutant mice develop hypertension and exhibit significantly elevated blood pressure (BP) by 3 months of age. This hypertension appears to be caused by increased sympathetic tone, primarily attributable to a CNS defect. Our data further suggest that this defect involves an oxytocin-dependent sensitization of V1 vasopressin and non-NMDA glutamatergic receptor-mediated pathways, potentially within the medulla, leading to increased sympathetic outflow. These results indicate that D5 dopamine receptors modulate neuronal pathways regulating blood pressure responses and may provide new insights into mechanisms for some forms of essential hypertension in humans, a disease that afflicts up to 25% of the aged adult population in industrialized societies.

Citing Articles

An Overview on Renal and Central Regulation of Blood Pressure by Neuropeptide FF and Its Receptors.

Lee H, Feranil J, Jose P Int J Mol Sci. 2025; 25(24.

PMID: 39769048 PMC: 11675822. DOI: 10.3390/ijms252413284.


Chemokinergic and Dopaminergic Signalling Collaborates through the Heteromer Formed by CCR9 and Dopamine Receptor D5 Increasing the Migratory Speed of Effector CD4 T-Cells to Infiltrate the Colonic Mucosa.

Campos J, Osorio-Barrios F, Villanelo F, Gutierrez-Maldonado S, Vargas P, Perez-Acle T Int J Mol Sci. 2024; 25(18).

PMID: 39337509 PMC: 11432204. DOI: 10.3390/ijms251810022.


Renal autocrine neuropeptide FF (NPFF) signaling regulates blood pressure.

Lee H, Amatya B, Villar V, Asico L, Jeong J, Feranil J Sci Rep. 2024; 14(1):15407.

PMID: 38965251 PMC: 11224344. DOI: 10.1038/s41598-024-64484-9.


Role of Dopamine in the Heart in Health and Disease.

Neumann J, Hofmann B, Dhein S, Gergs U Int J Mol Sci. 2023; 24(5).

PMID: 36902474 PMC: 10003060. DOI: 10.3390/ijms24055042.


Peroxiredoxin-4 and Dopamine D5 Receptor Interact to Reduce Oxidative Stress and Inflammation in the Kidney.

Amatya B, Yang S, Yu P, de Castro P, Armando I, Zeng C Antioxid Redox Signal. 2022; 38(16-18):1150-1166.

PMID: 36401517 PMC: 10262345. DOI: 10.1089/ars.2022.0034.


References
1.
Butcher K, Cechetto D . Neurotransmission in the medulla mediating insular cortical and lateral hypothalamic sympathetic responses. Can J Physiol Pharmacol. 1999; 76(7-8):737-46. DOI: 10.1139/cjpp-76-7-8-737. View

2.
Sibley D . New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol. 1999; 39:313-41. DOI: 10.1146/annurev.pharmtox.39.1.313. View

3.
Jiang D, Sibley D . Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization. Mol Pharmacol. 1999; 56(4):675-83. View

4.
Araujo G, Lopes O, Campos R . Importance of glycinergic and glutamatergic synapses within the rostral ventrolateral medulla for blood pressure regulation in conscious rats. Hypertension. 1999; 34(4 Pt 2):752-5. DOI: 10.1161/01.hyp.34.4.752. View

5.
Schetz J, Benjamin P, Sibley D . Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology. Mol Pharmacol. 2000; 57(1):144-52. View